Signs for "Heroes work here" outside healthcare facilities and even the homes of clinicians have popped up across the country. This photo shows healthcare workers at the Lenox Health emergency room entrance being greeted to cheers and thanks for their essential service during the COVID-19 pandemic in New York City at a public thank you event May 21, 2020. #COVID19 #SARScov2 #pandemic #LenoxHill 
Blog | Coronavirus (COVID-19)
Cardiology Stands Up to the COVID-19 Challenge 

Prior to January 2020 when clinicians read about the history of the 1918 flu, and epidemiologists predicted we were ...

Home June 22, 2020
Home
SMT Enters Structural Heart Market With Acquisition of Vascular Concepts. The company's Hydra TAVR (TAVI) valve gained European CE mark clearance in June 2020.
News | Heart Valve Technology
SMT Enters Structural Heart Market With Acquisition of Vascular Concepts

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device ...

Home June 19, 2020
Home
iVascular Launches Essential Pro Coronary Drug-coated Balloon
News | Drug-Eluting Balloons
iVascular Launches Essential Pro Coronary Drug-coated Balloon

June 19, 2020 — iVascular SLU announced the global launch of Essential Pro, a novel coronary artery drug-coated balloon ...

Home June 19, 2020
Home
MedAlliance announced its second CE mark approval for its Selution SLR 0.014 percutaneous transluminal coronary angioplasty (PTCA) sirolimus drug-eluting balloon (DEB) for the treatment of coronary artery disease. This includes indications for both de-novo lesions as well as in-stent restenosis. The approval applies to a broad range of balloon sizes, from 1.5 x 10 mm, up to 5 x 40 mm.
News | Drug-Eluting Balloons
MedAlliance Sirolimus Drug Eluting Balloon Gains Second European CE Mark

June 17, 2020 — MedAlliance announced its second CE mark approval for its Selution SLR 0.014 percutaneous transluminal ...

Home June 18, 2020
Home
he 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent showed low rates of revascularization and compared very favorably to current standards of care.  The results were presented by Professor Thomas Zeller, M.D., University Heart Centre Freiburg, Bad Krozingen, Germany at the CX 2020 Live conference.   
News | Peripheral Artery Disease (PAD)
Excellent 3-year Results in MIMICS-2 Study of the BioMimics 3D Vascular Stent 

June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent ...

Home June 16, 2020
Home
Biotronik Launchs His-Bundle Pacing Tools
News | Pacemakers
Biotronik Launches His-Bundle Pacing Tools

June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...

Home June 16, 2020
Home
Health Canada and the U.S. Food and Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied for the treatment of ventricular tachycardia (VT), a leading cause of sudden cardiac death worldwide.
News
FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. FDA says hydroxychloroquine does not work to treat COVID-19.Getty Images #COVID19 #COVID19update #SARSCoV2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine for COVID-19

June 15, 2020 — The U.S. Food and Drug Administration (FDA) today revoked the emergency use authorization (EUA) that ...

Home June 15, 2020
Home
Videos | Heart Valve Technology
VIDEO: Explaining Bicupid Aortic Valves

Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this ...

Home June 10, 2020
Home
At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle, and a still micropunture sheath.
Feature | Vascular Access | Dave Fornell, Editor
Use of Ultrasound to Improve Vascular Access

Vascular access site bleeding is associated with higher complications and mortality rates. For decades femoral access ...

Home June 10, 2020
Home
Centricity Cardio Enterprise[1] is an integrated Cardiovascular PACS (CVPACS) and Information System (CVIS) that bridges the gaps between care areas and healthcare information systems. You get a single point of access for patient data, wave forms, images, analysis tools and physician reports – combined with powerful end-to-end management, analytics and workflow tools across the cardiovascular care pathway.
Webinar | Coronavirus (COVID-19)
WEBINAR: Key Cardiovascular Metrics to Optimize Financial and Operational Outcomes

The financial burden of COVID-19 has put tremendous pressure on health systems across the country. This webinar will ...

Home June 10, 2020
Home
A PCR genetic test nasal swab being taken from a patient to test if they are infected with COVID-19. While used as the primary test to diagnose coronavirus, up to 20 percent of patients will test negative even eight days after infection. Getty Images
News | Coronavirus (COVID-19)
COVID-19 Genetic PCR Tests Give False Negative Results if Used Too Early

June 10, 2020 — In a new study, Johns Hopkins researchers found that testing people for SARS-CoV-2 (COVID-19) too early ...

Home June 10, 2020
Home
SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company of India focused on cardiology, announced it Hydra transcatheter aortic valve replacement (TAVR) device received European CE mark approval. It is indicated for the treatment of patients diagnosed with aortic stenosis. #SMT #HYDRA #TAVR
Feature | Heart Valve Technology
SMT Hydra TAVR System Receives European CE Mark Approval

June 9, 2020 — SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company in India focused on ...

Home June 09, 2020
Home
Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI.
Feature | CT Angiography (CTA) | Dave Fornell, Editor
New Technologies Take Cardiac CT to the Next Level

Here is an overview of a few of the biggest technology advances in cardiovascular computed tomography (CT). These are ...

Home June 08, 2020
Home
News | Heart Valve Technology
Edwards Sapien 3 Transcatheter Heart Valve Receives Approval In China

June 8, 2020 — Edwards Lifesciences Corp. announced Chinese regulatory approval for the Edwards Sapien 3 transcatheter ...

Home June 08, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now